Forbes August 15, 2024
Weight loss prescriptions Wegovy, Rybelsus and Saxenda—along with Ozempic—are the “single biggest driver” of employer health costs, adding 1% to the total premium expense for 2025, new data from the benefits consultancy Aon says.
These GLP-1 drugs are adding to general healthcare inflation that is projected to increase employer-sponsored health insurance coverage by 9%, eclipsing $16,000 per employee in 2025. The spike in premiums, which is higher than the 6.4% increase employers faced this year and in 2023, comes before any “cost savings strategies” are implemented, Aon said.
Employees, too, can expect higher co-payments, deductibles and premiums deducted from their paychecks because employers shift about 20% of their total premium costs onto workers, though this can vary widely depending on...
Today's Sponsors
Today's Sponsor